Pathogenesis of aplastic anemia

References

• Bär C, Povedano JM, Serrano R, et al. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia. Blood. 2016;127:1770–1779. doi: 10.1182/blood-2015-08-667485
   PubMed Web of Science ®Google Scholar
• Fan R, Wang W, Wang XQ, et al. Incidence of adult acquired severe aplastic anemia was not increased in Shanghai, China. Ann Hematol. 2011;90:1239–1240. doi: 10.1007/s00277-011-1168-5
   PubMed Web of Science ®Google Scholar
• Akram Z, Ahmed P, Kajigaya S, et al. Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan. Ann Hematol. 2019;98:301–312. doi: 10.1007/s00277-018-3542-z
   PubMed Web of Science ®Google Scholar
• Li SS, Hsu YT, Chang C, et al. Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database. Ann Hematol. 2019;98:29–39. doi: 10.1007/s00277-018-3486-3
   PubMed Web of Science ®Google Scholar
• Nakagawa MM, Rathinam CV. Constitutive activation of the canonical NF-kappaB pathway leads to bone marrow failure and induction of erythroid signature in hematopoietic stem cells. Cell Rep. 2018;25:2094–2109. e2094. doi: 10.1016/j.celrep.2018.10.071
   PubMed Web of Science ®Google Scholar
• Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135:1118–1129. doi: 10.1016/j.cell.2008.10.048
   PubMed Web of Science ®Google Scholar
• Sertorio M, Du W, Amarachintha S, et al. In vivo RNAi screen unveils PPARgamma as a regulator of hematopoietic stem cell homeostasis. Stem Cell Rep. 2017;8:1242–1255. doi: 10.1016/j.stemcr.2017.03.008
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Selleri C, Sato T, et al. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood. 1996;88:1983–1991.
   PubMed Web of Science ®Google Scholar
• Scopes J, Daly S, Atkinson R, et al. Aplastic anemia: evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony-stimulating factor in vitro. Blood. 1996;87:3179–3185.
   PubMed Web of Science ®Google Scholar
• de Bruin AM, Demirel O, Hooibrink B, et al. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood. 2013;121:3578–3585. doi: 10.1182/blood-2012-05-432906
   PubMed Web of Science ®Google Scholar
• Ismail M, Gibson FM, Gordon-Smith EC, et al. Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen. Br J Haematol. 2001;113:706–712. doi: 10.1046/j.1365-2141.2001.02810.x
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Selleri C, Sato T, et al. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol. 1995;91:245–252. doi: 10.1111/j.1365-2141.1995.tb05277.x
   PubMed Web of Science ®Google Scholar
• Callera F, Falcao RP. Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia. Br J Haematol. 1997;98:18–20. doi: 10.1046/j.1365-2141.1997.1532971.x
   PubMed Web of Science ®Google Scholar
• Scopes J, Bagnara M, Gordon-Smith EC, et al. Haemopoietic progenitor cells are reduced in aplastic anaemia. Br J Haematol. 1994;86:427–430. doi: 10.1111/j.1365-2141.1994.tb04761.x
   PubMed Web of Science ®Google Scholar
• Timeus F, Crescenzio N, Doria A, et al. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia. Exp Hematol. 2005;33:597–604. doi: 10.1016/j.exphem.2005.02.005
   PubMed Web of Science ®Google Scholar
• Holmberg LA, Seidel K, Leisenring W, et al. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood. 1994;84:3685–3690.
   PubMed Web of Science ®Google Scholar
• Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764. doi: 10.1016/S0092-8674(00)80258-5
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841–846. doi: 10.1038/nature02040
   PubMed Web of Science ®Google Scholar
• Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:637–643. doi: 10.1038/nature12612
   PubMed Web of Science ®Google Scholar
• Yoon KA, Cho HS, Shin HI, et al. Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. Stem Cells Dev. 2012;21:3391–3402. doi: 10.1089/scd.2012.0128
   PubMed Web of Science ®Google Scholar
• Wu L, Mo W, Zhang Y, et al. Impairment of hematopoietic stem cell niches in patients with aplastic anemia. Int J Hematol. 2015;102:645–653. doi: 10.1007/s12185-015-1881-2
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8:315–317. doi: 10.1080/14653240600855905
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Haynesworth SE, et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res.. 2000;9:841–848. doi: 10.1089/152581600750062264
   PubMedGoogle Scholar
• Gao F, Chiu SM, Motan DA, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062. doi: 10.1038/cddis.2015.327
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Valle M, Podesta M, et al. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol. 2005;33:819–827. doi: 10.1016/j.exphem.2005.05.006
   PubMed Web of Science ®Google Scholar
• Chao YH, Peng CT, Harn HJ, et al. Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol. 2010;89:715–723. doi: 10.1007/s00277-009-0892-6
   PubMed Web of Science ®Google Scholar
• Chao YH, Tsai C, Peng CT, et al. Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant. 2011;46:1391–1392. doi: 10.1038/bmt.2010.305
   PubMed Web of Science ®Google Scholar
• Gonzaga VF, Wenceslau CV, Lisboa GS, et al. Mesenchymal stem cell benefits observed in bone marrow failure and acquired aplastic anemia. Stem Cells Int. 2017;2017:8076529. doi: 10.1155/2017/8076529
   PubMed Web of Science ®Google Scholar
• Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509–2519. doi: 10.1182/blood-2006-03-010777
   PubMed Web of Science ®Google Scholar
• Chen J, Desierto MJ, Feng X, et al. Immune-mediated bone marrow failure in C57BL/6 mice. Exp Hematol. 2015;43:256–267. doi: 10.1016/j.exphem.2014.12.006
   PubMed Web of Science ®Google Scholar
• Young NS. Hematopoietic cell destruction by immune mechanismsn acquired aplastic anemia. Semin Hematol. 2000;37:3–14. doi: 10.1016/S0037-1963(00)90026-X
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European group for blood and marrow transplantation (EBMT). Haematologica. 2007;92:11–18. doi: 10.3324/haematol.10075
   PubMed Web of Science ®Google Scholar
• Chuncharunee S, Wong R, Rojnuckarin P, et al. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Int J Hematol. 2016;104:454–461. doi: 10.1007/s12185-016-2053-8
   PubMed Web of Science ®Google Scholar
• Grossmayer GE, Munoz LE, Gaipl US, et al. Removal of dying cells and systemic lupus erythematosus. Mod Rheumatol. 2005;15:383–390. doi: 10.3109/s10165-005-0430-x
   PubMedGoogle Scholar
• Liu C, Li Z, Sheng W, et al. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Immunol Invest. 2014;43:491–503. doi: 10.3109/08820139.2014.888448
   PubMed Web of Science ®Google Scholar
• Barnes DW, Mole RH. Aplastic anaemia in sublethally irradiated mice given allogeneic lymph node cells. Br J Haematol. 1967;13:482–491. doi: 10.1111/j.1365-2141.1967.tb00758.x
   PubMed Web of Science ®Google Scholar
• Hinterberger W, Rowlings PA, Hinterberger-Fischer M, et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med. 1997;126:116–122. doi: 10.7326/0003-4819-126-2-199701150-00004
   PubMed Web of Science ®Google Scholar
• Li JP, Zheng CL, Han ZC. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol. 2010;75:79–93. doi: 10.1016/j.critrevonc.2009.12.001
   PubMed Web of Science ®Google Scholar
• Giannakoulas NC, Karakantza M, Theodorou GL, et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients. Br J Haematol. 2004;124:97–105. doi: 10.1046/j.1365-2141.2003.04729.x
   PubMed Web of Science ®Google Scholar
• Kordasti S, Marsh J, Al-Khan S, et al. Functional characterization of CD4+ T cells in aplastic anemia. Blood. 2012;119:2033–2043. doi: 10.1182/blood-2011-08-368308
   PubMed Web of Science ®Google Scholar
• Schuster FR, Hubner B, Fuhrer M, et al. Highly skewed T-cell receptor V-beta chain repertoire in the bone marrow is associated with response to immunosuppressive drug therapy in children with very severe aplastic anemia. Blood Cancer J. 2011;1:e8. doi: 10.1038/bcj.2011.6
   PubMed Web of Science ®Google Scholar
• Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol. 2005;84:572–577. doi: 10.1007/s00277-005-1022-8
   PubMed Web of Science ®Google Scholar
• Dufour C, Ferretti E, Bagnasco F, et al. Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia. Haematologica. 2009;94:1743–1747. doi: 10.3324/haematol.2009.007815
   PubMed Web of Science ®Google Scholar
• Hinterberger W, Adolf G, Bettelheim P, et al. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood. 1989;74:2713–2717.
   PubMed Web of Science ®Google Scholar
• Liu H, Mihara K, Song G, et al. Interferon-gamma attenuates the survival activity of G-CSF through PI3 K/Akt signaling pathway in mouse multipotent progenitor cells. Ann Hematol. 2007;86:547–555. doi: 10.1007/s00277-007-0308-4
   PubMed Web of Science ®Google Scholar
• Arens R, Tesselaar K, Baars PA, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001;15:801–812. doi: 10.1016/S1074-7613(01)00236-9
   PubMed Web of Science ®Google Scholar
• Libregts SF, Gutierrez L, de Bruin AM, et al. Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood. 2011;118:2578–2588. doi: 10.1182/blood-2010-10-315218
   PubMed Web of Science ®Google Scholar
• de Bruin AM, Buitenhuis M, van der Sluijs KF, et al. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood. 2010;116:2559–2569. doi: 10.1182/blood-2009-12-261339
   PubMed Web of Science ®Google Scholar
• de Bruin AM, Libregts SF, Valkhof M, et al. IFN-gamma induces monopoiesis and inhibits neutrophil development during inflammation. Blood. 2012;119:1543–1554. doi: 10.1182/blood-2011-07-367706
   PubMed Web of Science ®Google Scholar
• Dufour C, Capasso M, Svahn J, et al. Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol. 2004;126:682–685. doi: 10.1111/j.1365-2141.2004.05102.x
   PubMed Web of Science ®Google Scholar
• Fermo E, Bianchi P, Barcellini W, et al. Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia. Eur J Immunogenet Off J Brit Soc Histocompatibility Immunogenet. 2004;31:267–269. doi: 10.1111/j.1365-2370.2004.00480.x
   Web of Science ®Google Scholar
• Serio B, Selleri C, Maciejewski JP. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem. 2011;11:544–552. doi: 10.2174/138955711795843356
   PubMed Web of Science ®Google Scholar
• Lin FC, Karwan M, Saleh B, et al. IFN-gamma causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation. Blood. 2014;124:3699–3708. doi: 10.1182/blood-2014-01-549527
   PubMed Web of Science ®Google Scholar
• Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res. 2005;15:24–27. doi: 10.1038/sj.cr.7290259
   PubMed Web of Science ®Google Scholar
• Sun W, Wu Z, Lin Z, et al. Macrophage TNF-alpha licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia. Blood. 2018;132:2730–2743. doi: 10.1182/blood-2018-05-844928
   PubMed Web of Science ®Google Scholar
• Vila-del Sol V, Punzon C, Fresno M. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol (Baltimore, Md.: 1950). 2008;181:4461–4470. doi: 10.4049/jimmunol.181.7.4461
   PubMed Web of Science ®Google Scholar
• Gidvani V, Ramkissoon S, Sloand EM, et al. Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol. 2007;82:721–724. doi: 10.1002/ajh.20881
   PubMed Web of Science ®Google Scholar
• Eder M, Geissler G, Ganser A. IL-3 in the clinic. Stem Cells. 1997;15:327–333. doi: 10.1002/stem.150327
   PubMed Web of Science ®Google Scholar
• Cork BA, Tuckerman EM, Li TC, et al. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod. 2002;8:841–848. doi: 10.1093/molehr/8.9.841
   PubMed Web of Science ®Google Scholar
• Zaimoku Y, Takamatsu H, Hosomichi K, et al. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood. 2017;129:2908–2916. doi: 10.1182/blood-2016-11-752378
   PubMed Web of Science ®Google Scholar
• Gao GF, Jakobsen BK. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol Today. 2000;21:630–636. doi: 10.1016/S0167-5699(00)01750-3
   PubMedGoogle Scholar
• Maruyama H, Katagiri T, Kashiwase K, et al. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia. Exp Hematol. 2016;44(10):931–939. e933. doi: 10.1016/j.exphem.2016.05.013
   PubMed Web of Science ®Google Scholar
• Gonzalez-Galarza FF, Takeshita LY, Santos EJ, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;43(Database issue):D784–D788. doi: 10.1093/nar/gku1166
   PubMed Web of Science ®Google Scholar
• Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016;128(3):337–347. doi: 10.1182/blood-2016-01-636381
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Green S, et al. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet (London. England. 2004;364:355–364.
   Google Scholar
• Tichelli A, Schrezenmeier H, Socie G, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the European group for blood and marrow transplantation. Blood. 2011;117:4434–4441. doi: 10.1182/blood-2010-08-304071
   PubMed Web of Science ®Google Scholar
• Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373:35–47. doi: 10.1056/NEJMoa1414799
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kosaka H, Maeda Y, et al. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood. 2002;100:4116–4122. doi: 10.1182/blood-2002-06-1669
   PubMed Web of Science ®Google Scholar
• Gargiulo L, Papaioannou M, Sica M, et al. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121:2753–2761. doi: 10.1182/blood-2012-11-469353
   PubMed Web of Science ®Google Scholar
• Kulasekararaj AG, Jiang J, Smith AE, et al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 2014;124:2698–2704. doi: 10.1182/blood-2014-05-574889
   PubMed Web of Science ®Google Scholar
• Marsh JC, Kulasekararaj AG. Management of the refractory aplastic anemia patient: what are the options? Blood. 2013;122:3561–3567. doi: 10.1182/blood-2013-05-498279
   PubMed Web of Science ®Google Scholar
• de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–2110. doi: 10.1101/gad.1346005
   PubMed Web of Science ®Google Scholar
• Sakaguchi H, Nishio N, Hama A, et al. Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia. Haematologica. 2014;99:1312–1316. doi: 10.3324/haematol.2013.091165
   PubMed Web of Science ®Google Scholar
• Brummendorf TH, Maciejewski JP, Mak J, et al. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97:895–900. doi: 10.1182/blood.V97.4.895
   PubMed Web of Science ®Google Scholar
• Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol. 2015;180:361–370. doi: 10.1111/cei.12605
   PubMed Web of Science ®Google Scholar